ICD-10 Coding for Antinuclear Antibody Positive(M32.9, R76.0, R76.0B)
Comprehensive guide on ICD-10 coding for antinuclear antibody positive tests, including documentation requirements and coding pitfalls.
Complete code families applicable to Antinuclear Antibody Positive
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated without a specific pattern and no confirmed autoimmune disease. |
|
| R76.8 | Other specified abnormal immunological findings in serum | Use when ANA test shows specific patterns. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAntinuclear Antibody Positive
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Antinuclear Antibody Positive.
Documenting 'ANA positive' without details.
Impact
Clinical: Inadequate information for diagnosis., Regulatory: Potential audit issues., Financial: Claims may be denied due to insufficient documentation.
Mitigation
Always include titer and pattern in notes., Educate staff on documentation standards.
Using R76.0 as a primary diagnosis.
Impact
Reimbursement: Claims may be denied., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Always use R76.0 as a secondary code.
Documentation of ANA results
Impact
Incomplete documentation can lead to audit issues.
Mitigation
Ensure all ANA test details are recorded.